Targeting PD-1/PD-L-1 immune checkpoint inhibition for cancer immunotherapy: success and challenges

Overview of attention for article published in Frontiers in immunology, April 2024

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 43,315 followers.

Targeting PD-1/PD-L-1 immune checkpoint inhibition for cancer immunotherapy: success and challenges https://t.co/DpjBY9QL2O #FrontImmunol

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.